NervGen Pharma Corp. (NGEN)
NASDAQ: NGEN · Real-Time Price · USD
3.970
+0.090 (2.32%)
Apr 22, 2026, 1:08 PM EDT - Market open
NervGen Pharma Market Cap
NervGen Pharma has a market cap or net worth of $321.3 million as of April 22, 2026. Its market cap has increased by 118.65% in one year.
Market Cap
321.30M
Enterprise Value
309.25M
1-Year Change
118.65%
Ranking
Category
Stock Price
$3.97
Market Cap Chart
Since April 3, 2019, NervGen Pharma's market cap has increased from $37.43M to $321.30M, an increase of 758.40%. That is a compound annual growth rate of 35.63%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 21, 2026 | 314.01M | -29.55% |
| Dec 31, 2025 | 445.73M | 190.81% |
| Dec 31, 2024 | 153.27M | 26.05% |
| Dec 29, 2023 | 121.60M | 74.14% |
| Dec 30, 2022 | 69.83M | -27.73% |
| Dec 31, 2021 | 96.62M | 58.13% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Apr 3, 2019 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Editas Medicine | 341.57M |
| Anavex Life Sciences | 337.33M |
| Zentalis Pharmaceuticals | 329.12M |
| Cellectis | 324.09M |
| LENZ Therapeutics | 319.19M |
| Abeona Therapeutics | 313.77M |
| NovaBridge Biosciences | 312.25M |
| Inhibikase Therapeutics | 311.87M |